Global Generic Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
The Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Generic Drugs size is estimated to be million in 2021 from USD 293440 million in 2020, with a change of % between 2020 and 2021. The global Generic Drugs market size is expected to grow at a CAGR of 9.6% for the next five years.
Market segmentation
Generic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Drugs, with price, sales, revenue and global market share of Generic Drugs in 2018 and 2019.
Chapter 3, the Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our latest research, the global Generic Drugs size is estimated to be million in 2021 from USD 293440 million in 2020, with a change of % between 2020 and 2021. The global Generic Drugs market size is expected to grow at a CAGR of 9.6% for the next five years.
Market segmentation
Generic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Simple Generic Drugs
- Super Generic Drugs
- Biosimilars
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
- Teva
- Novartis - Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Drugs, with price, sales, revenue and global market share of Generic Drugs in 2018 and 2019.
Chapter 3, the Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Generic Drugs Market Size & Forecast
1.4.1 Global Generic Drugs Sales in Value (2016-2026))
1.4.2 Global Generic Drugs Sales in Volume (2016-2026)
1.4.3 Global Generic Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Generic Drugs Production Capacity Analysis
1.5.1 Global Generic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Generic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Drugs Market Drivers
1.6.2 Generic Drugs Market Restraints
1.6.3 Generic Drugs Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Generic Drugs Product and Services
2.1.4 Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis - Sandoz
2.2.1 Novartis - Sandoz Details
2.2.2 Novartis - Sandoz Major Business
2.2.3 Novartis - Sandoz Generic Drugs Product and Services
2.2.4 Novartis - Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Generic Drugs Product and Services
2.3.4 Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Generic Drugs Product and Services
2.4.4 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Aspen
2.5.1 Aspen Details
2.5.2 Aspen Major Business
2.5.3 Aspen Generic Drugs Product and Services
2.5.4 Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Generic Drugs Product and Services
2.6.4 Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer (Hospira)
2.7.1 Pfizer (Hospira) Details
2.7.2 Pfizer (Hospira) Major Business
2.7.3 Pfizer (Hospira) Generic Drugs Product and Services
2.7.4 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Generic Drugs Product and Services
2.8.4 Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Aurobindo
2.9.1 Aurobindo Details
2.9.2 Aurobindo Major Business
2.9.3 Aurobindo Generic Drugs Product and Services
2.9.4 Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Lupin
2.10.1 Lupin Details
2.10.2 Lupin Major Business
2.10.3 Lupin Generic Drugs Product and Services
2.10.4 Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Dr. Reddy's
2.11.1 Dr. Reddy's Details
2.11.2 Dr. Reddy's Major Business
2.11.3 Dr. Reddy's Generic Drugs Product and Services
2.11.4 Dr. Reddy's Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Apotex
2.12.1 Apotex Details
2.12.2 Apotex Major Business
2.12.3 Apotex Generic Drugs Product and Services
2.12.4 Apotex Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Generic Drugs Product and Services
2.13.4 Cipla Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 ENDO (Par Pharmaceutical)
2.14.1 ENDO (Par Pharmaceutical) Details
2.14.2 ENDO (Par Pharmaceutical) Major Business
2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Product and Services
2.14.4 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Stada Arzneimittel
2.15.1 Stada Arzneimittel Details
2.15.2 Stada Arzneimittel Major Business
2.15.3 Stada Arzneimittel Generic Drugs Product and Services
2.15.4 Stada Arzneimittel Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Krka Group
2.16.1 Krka Group Details
2.16.2 Krka Group Major Business
2.16.3 Krka Group Generic Drugs Product and Services
2.16.4 Krka Group Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Nichi-Iko Pharmaceutical
2.17.1 Nichi-Iko Pharmaceutical Details
2.17.2 Nichi-Iko Pharmaceutical Major Business
2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Product and Services
2.17.4 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Valeant
2.18.1 Valeant Details
2.18.2 Valeant Major Business
2.18.3 Valeant Generic Drugs Product and Services
2.18.4 Valeant Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Zydus Cadila
2.19.1 Zydus Cadila Details
2.19.2 Zydus Cadila Major Business
2.19.3 Zydus Cadila Generic Drugs Product and Services
2.19.4 Zydus Cadila Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Hikma
2.20.1 Hikma Details
2.20.2 Hikma Major Business
2.20.3 Hikma Generic Drugs Product and Services
2.20.4 Hikma Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 GENERIC DRUGS SALES BY MANUFACTURER
3.1 Global Generic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Generic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Generic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Generic Drugs Manufacturer Market Share
3.4.2 Top 6 Generic Drugs Manufacturer Market Share
3.5 Global Generic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Generic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Generic Drugs Market Size by Region
4.1.1 Global Generic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Generic Drugs Revenue by Region (2016-2026)
4.2 North America Generic Drugs Revenue (2016-2026)
4.3 Europe Generic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Generic Drugs Revenue (2016-2026)
4.5 South America Generic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Generic Drugs Revenue (2016-2026)
5 MARKET SEGMENT BY TYPE
5.1 Global Generic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Generic Drugs Revenue by Type (2016-2026)
5.3 Global Generic Drugs Price by Type (2016-2026)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Generic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Generic Drugs Revenue by Application (2016-2026)
6.3 Global Generic Drugs Price by Application (2016-2026)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Generic Drugs Sales by Type (2016-2026)
7.2 North America Generic Drugs Sales by Application (2016-2026)
7.3 North America Generic Drugs Market Size by Country
7.3.1 North America Generic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Generic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Generic Drugs Sales by Type (2016-2026)
8.2 Europe Generic Drugs Sales by Application (2016-2026)
8.3 Europe Generic Drugs Market Size by Country
8.3.1 Europe Generic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Generic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 ASIA-PACIFIC BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Generic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Generic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Generic Drugs Market Size by Region
9.3.1 Asia-Pacific Generic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Generic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 South America Generic Drugs Sales by Type (2016-2026)
10.2 South America Generic Drugs Sales by Application (2016-2026)
10.3 South America Generic Drugs Market Size by Country
10.3.1 South America Generic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Generic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Generic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Generic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Generic Drugs Market Size by Country
11.3.1 Middle East & Africa Generic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Generic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Generic Drugs Typical Distributors
12.3 Generic Drugs Typical Customers
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Generic Drugs Market Size & Forecast
1.4.1 Global Generic Drugs Sales in Value (2016-2026))
1.4.2 Global Generic Drugs Sales in Volume (2016-2026)
1.4.3 Global Generic Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Generic Drugs Production Capacity Analysis
1.5.1 Global Generic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Generic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Drugs Market Drivers
1.6.2 Generic Drugs Market Restraints
1.6.3 Generic Drugs Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Generic Drugs Product and Services
2.1.4 Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis - Sandoz
2.2.1 Novartis - Sandoz Details
2.2.2 Novartis - Sandoz Major Business
2.2.3 Novartis - Sandoz Generic Drugs Product and Services
2.2.4 Novartis - Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Generic Drugs Product and Services
2.3.4 Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Generic Drugs Product and Services
2.4.4 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Aspen
2.5.1 Aspen Details
2.5.2 Aspen Major Business
2.5.3 Aspen Generic Drugs Product and Services
2.5.4 Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Generic Drugs Product and Services
2.6.4 Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer (Hospira)
2.7.1 Pfizer (Hospira) Details
2.7.2 Pfizer (Hospira) Major Business
2.7.3 Pfizer (Hospira) Generic Drugs Product and Services
2.7.4 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Generic Drugs Product and Services
2.8.4 Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Aurobindo
2.9.1 Aurobindo Details
2.9.2 Aurobindo Major Business
2.9.3 Aurobindo Generic Drugs Product and Services
2.9.4 Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Lupin
2.10.1 Lupin Details
2.10.2 Lupin Major Business
2.10.3 Lupin Generic Drugs Product and Services
2.10.4 Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Dr. Reddy's
2.11.1 Dr. Reddy's Details
2.11.2 Dr. Reddy's Major Business
2.11.3 Dr. Reddy's Generic Drugs Product and Services
2.11.4 Dr. Reddy's Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Apotex
2.12.1 Apotex Details
2.12.2 Apotex Major Business
2.12.3 Apotex Generic Drugs Product and Services
2.12.4 Apotex Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Generic Drugs Product and Services
2.13.4 Cipla Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 ENDO (Par Pharmaceutical)
2.14.1 ENDO (Par Pharmaceutical) Details
2.14.2 ENDO (Par Pharmaceutical) Major Business
2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Product and Services
2.14.4 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Stada Arzneimittel
2.15.1 Stada Arzneimittel Details
2.15.2 Stada Arzneimittel Major Business
2.15.3 Stada Arzneimittel Generic Drugs Product and Services
2.15.4 Stada Arzneimittel Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Krka Group
2.16.1 Krka Group Details
2.16.2 Krka Group Major Business
2.16.3 Krka Group Generic Drugs Product and Services
2.16.4 Krka Group Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Nichi-Iko Pharmaceutical
2.17.1 Nichi-Iko Pharmaceutical Details
2.17.2 Nichi-Iko Pharmaceutical Major Business
2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Product and Services
2.17.4 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Valeant
2.18.1 Valeant Details
2.18.2 Valeant Major Business
2.18.3 Valeant Generic Drugs Product and Services
2.18.4 Valeant Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Zydus Cadila
2.19.1 Zydus Cadila Details
2.19.2 Zydus Cadila Major Business
2.19.3 Zydus Cadila Generic Drugs Product and Services
2.19.4 Zydus Cadila Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Hikma
2.20.1 Hikma Details
2.20.2 Hikma Major Business
2.20.3 Hikma Generic Drugs Product and Services
2.20.4 Hikma Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 GENERIC DRUGS SALES BY MANUFACTURER
3.1 Global Generic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Generic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Generic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Generic Drugs Manufacturer Market Share
3.4.2 Top 6 Generic Drugs Manufacturer Market Share
3.5 Global Generic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Generic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Generic Drugs Market Size by Region
4.1.1 Global Generic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Generic Drugs Revenue by Region (2016-2026)
4.2 North America Generic Drugs Revenue (2016-2026)
4.3 Europe Generic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Generic Drugs Revenue (2016-2026)
4.5 South America Generic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Generic Drugs Revenue (2016-2026)
5 MARKET SEGMENT BY TYPE
5.1 Global Generic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Generic Drugs Revenue by Type (2016-2026)
5.3 Global Generic Drugs Price by Type (2016-2026)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Generic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Generic Drugs Revenue by Application (2016-2026)
6.3 Global Generic Drugs Price by Application (2016-2026)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Generic Drugs Sales by Type (2016-2026)
7.2 North America Generic Drugs Sales by Application (2016-2026)
7.3 North America Generic Drugs Market Size by Country
7.3.1 North America Generic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Generic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Generic Drugs Sales by Type (2016-2026)
8.2 Europe Generic Drugs Sales by Application (2016-2026)
8.3 Europe Generic Drugs Market Size by Country
8.3.1 Europe Generic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Generic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 ASIA-PACIFIC BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Generic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Generic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Generic Drugs Market Size by Region
9.3.1 Asia-Pacific Generic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Generic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 South America Generic Drugs Sales by Type (2016-2026)
10.2 South America Generic Drugs Sales by Application (2016-2026)
10.3 South America Generic Drugs Market Size by Country
10.3.1 South America Generic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Generic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Generic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Generic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Generic Drugs Market Size by Country
11.3.1 Middle East & Africa Generic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Generic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Generic Drugs Typical Distributors
12.3 Generic Drugs Typical Customers
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Generic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Generic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Generic Drugs Product and Services
Table 6. Teva Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis - Sandoz Basic Information, Manufacturing Base and Competitors
Table 8. Novartis - Sandoz Major Business
Table 9. Novartis - Sandoz Generic Drugs Product and Services
Table 10. Novartis - Sandoz Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Generic Drugs Product and Services
Table 14. Mylan Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharmaceutical Major Business
Table 17. Sun Pharmaceutical Generic Drugs Product and Services
Table 18. Sun Pharmaceutical Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aspen Basic Information, Manufacturing Base and Competitors
Table 20. Aspen Major Business
Table 21. Aspen Generic Drugs Product and Services
Table 22. Aspen Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi Major Business
Table 25. Fresenius Kabi Generic Drugs Product and Services
Table 26. Fresenius Kabi Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer (Hospira) Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer (Hospira) Major Business
Table 29. Pfizer (Hospira) Generic Drugs Product and Services
Table 30. Pfizer (Hospira) Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Generic Drugs Product and Services
Table 34. Sanofi Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 36. Aurobindo Major Business
Table 37. Aurobindo Generic Drugs Product and Services
Table 38. Aurobindo Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Lupin Basic Information, Manufacturing Base and Competitors
Table 40. Lupin Major Business
Table 41. Lupin Generic Drugs Product and Services
Table 42. Lupin Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 44. Dr. Reddy's Major Business
Table 45. Dr. Reddy's Generic Drugs Product and Services
Table 46. Dr. Reddy's Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Apotex Basic Information, Manufacturing Base and Competitors
Table 48. Apotex Major Business
Table 49. Apotex Generic Drugs Product and Services
Table 50. Apotex Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Cipla Basic Information, Manufacturing Base and Competitors
Table 52. Cipla Major Business
Table 53. Cipla Generic Drugs Product and Services
Table 54. Cipla Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. ENDO (Par Pharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 56. ENDO (Par Pharmaceutical) Major Business
Table 57. ENDO (Par Pharmaceutical) Generic Drugs Product and Services
Table 58. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 60. Stada Arzneimittel Major Business
Table 61. Stada Arzneimittel Generic Drugs Product and Services
Table 62. Stada Arzneimittel Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Krka Group Basic Information, Manufacturing Base and Competitors
Table 64. Krka Group Major Business
Table 65. Krka Group Generic Drugs Product and Services
Table 66. Krka Group Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Nichi-Iko Pharmaceutical Major Business
Table 69. Nichi-Iko Pharmaceutical Generic Drugs Product and Services
Table 70. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Valeant Basic Information, Manufacturing Base and Competitors
Table 72. Valeant Major Business
Table 73. Valeant Generic Drugs Product and Services
Table 74. Valeant Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 76. Zydus Cadila Major Business
Table 77. Zydus Cadila Generic Drugs Product and Services
Table 78. Zydus Cadila Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Hikma Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Major Business
Table 81. Hikma Generic Drugs Product and Services
Table 82. Hikma Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Global Generic Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 84. Global Generic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 85. Market Position of Manufacturers in Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 86. Global Generic Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 87. Head Office and Generic Drugs Production Site of Key Manufacturer
Table 88. Generic Drugs New Entrant and Capacity Expansion Plans
Table 89. Generic Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Generic Drugs Sales by Region (2016-2021e) & (K MT)
Table 91. Global Generic Drugs Sales by Region (2021-2026) & (K MT)
Table 92. Global Generic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 93. Global Generic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 94. Global Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 95. Global Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 96. Global Generic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 97. Global Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 98. Global Generic Drugs Price by Type (2016-2021e) & (USD/MT)
Table 99. Global Generic Drugs Price by Type (2021-2026) & (USD/MT)
Table 100. Global Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 101. Global Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 102. Global Generic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 103. Global Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 104. Global Generic Drugs Price by Application (2016-2021e) & (USD/MT)
Table 105. Global Generic Drugs Price by Application (2021-2026) & (USD/MT)
Table 106. North America Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 107. North America Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 108. North America Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 109. North America Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 110. North America Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 111. North America Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 112. North America Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 113. North America Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 114. Europe Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 115. Europe Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 116. Europe Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 117. Europe Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 118. Europe Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 119. Europe Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 120. Europe Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 121. Europe Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 122. Asia-Pacific Generic Drugs Sales by Region (2016-2021e) & (K MT)
Table 123. Asia-Pacific Generic Drugs Sales by Region (2021-2026) & (K MT)
Table 124. Asia-Pacific Generic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 125. Asia-Pacific Generic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 127. Asia-Pacific Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 128. Asia-Pacific Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 129. Asia-Pacific Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 130. South America Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 131. South America Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 132. South America Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 133. South America Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 134. South America Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 135. South America Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 136. South America Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 137. South America Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 138. Middle East & Africa Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 139. Middle East & Africa Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 140. Middle East & Africa Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 141. Middle East & Africa Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 142. Middle East & Africa Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 143. Middle East & Africa Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 144. Middle East & Africa Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 145. Middle East & Africa Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 146. Direct Channel Pros & Cons
Table 147. Indirect Channel Pros & Cons
Table 148. Generic Drugs Typical Distributors
Table 149. Generic Drugs Typical Customers
Table 1. Global Generic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Generic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Generic Drugs Product and Services
Table 6. Teva Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis - Sandoz Basic Information, Manufacturing Base and Competitors
Table 8. Novartis - Sandoz Major Business
Table 9. Novartis - Sandoz Generic Drugs Product and Services
Table 10. Novartis - Sandoz Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Generic Drugs Product and Services
Table 14. Mylan Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharmaceutical Major Business
Table 17. Sun Pharmaceutical Generic Drugs Product and Services
Table 18. Sun Pharmaceutical Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aspen Basic Information, Manufacturing Base and Competitors
Table 20. Aspen Major Business
Table 21. Aspen Generic Drugs Product and Services
Table 22. Aspen Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi Major Business
Table 25. Fresenius Kabi Generic Drugs Product and Services
Table 26. Fresenius Kabi Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer (Hospira) Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer (Hospira) Major Business
Table 29. Pfizer (Hospira) Generic Drugs Product and Services
Table 30. Pfizer (Hospira) Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Generic Drugs Product and Services
Table 34. Sanofi Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 36. Aurobindo Major Business
Table 37. Aurobindo Generic Drugs Product and Services
Table 38. Aurobindo Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Lupin Basic Information, Manufacturing Base and Competitors
Table 40. Lupin Major Business
Table 41. Lupin Generic Drugs Product and Services
Table 42. Lupin Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 44. Dr. Reddy's Major Business
Table 45. Dr. Reddy's Generic Drugs Product and Services
Table 46. Dr. Reddy's Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Apotex Basic Information, Manufacturing Base and Competitors
Table 48. Apotex Major Business
Table 49. Apotex Generic Drugs Product and Services
Table 50. Apotex Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Cipla Basic Information, Manufacturing Base and Competitors
Table 52. Cipla Major Business
Table 53. Cipla Generic Drugs Product and Services
Table 54. Cipla Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. ENDO (Par Pharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 56. ENDO (Par Pharmaceutical) Major Business
Table 57. ENDO (Par Pharmaceutical) Generic Drugs Product and Services
Table 58. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 60. Stada Arzneimittel Major Business
Table 61. Stada Arzneimittel Generic Drugs Product and Services
Table 62. Stada Arzneimittel Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Krka Group Basic Information, Manufacturing Base and Competitors
Table 64. Krka Group Major Business
Table 65. Krka Group Generic Drugs Product and Services
Table 66. Krka Group Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Nichi-Iko Pharmaceutical Major Business
Table 69. Nichi-Iko Pharmaceutical Generic Drugs Product and Services
Table 70. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Valeant Basic Information, Manufacturing Base and Competitors
Table 72. Valeant Major Business
Table 73. Valeant Generic Drugs Product and Services
Table 74. Valeant Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 76. Zydus Cadila Major Business
Table 77. Zydus Cadila Generic Drugs Product and Services
Table 78. Zydus Cadila Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Hikma Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Major Business
Table 81. Hikma Generic Drugs Product and Services
Table 82. Hikma Generic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Global Generic Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 84. Global Generic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 85. Market Position of Manufacturers in Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 86. Global Generic Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 87. Head Office and Generic Drugs Production Site of Key Manufacturer
Table 88. Generic Drugs New Entrant and Capacity Expansion Plans
Table 89. Generic Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Generic Drugs Sales by Region (2016-2021e) & (K MT)
Table 91. Global Generic Drugs Sales by Region (2021-2026) & (K MT)
Table 92. Global Generic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 93. Global Generic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 94. Global Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 95. Global Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 96. Global Generic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 97. Global Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 98. Global Generic Drugs Price by Type (2016-2021e) & (USD/MT)
Table 99. Global Generic Drugs Price by Type (2021-2026) & (USD/MT)
Table 100. Global Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 101. Global Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 102. Global Generic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 103. Global Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 104. Global Generic Drugs Price by Application (2016-2021e) & (USD/MT)
Table 105. Global Generic Drugs Price by Application (2021-2026) & (USD/MT)
Table 106. North America Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 107. North America Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 108. North America Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 109. North America Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 110. North America Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 111. North America Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 112. North America Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 113. North America Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 114. Europe Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 115. Europe Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 116. Europe Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 117. Europe Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 118. Europe Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 119. Europe Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 120. Europe Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 121. Europe Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 122. Asia-Pacific Generic Drugs Sales by Region (2016-2021e) & (K MT)
Table 123. Asia-Pacific Generic Drugs Sales by Region (2021-2026) & (K MT)
Table 124. Asia-Pacific Generic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 125. Asia-Pacific Generic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 127. Asia-Pacific Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 128. Asia-Pacific Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 129. Asia-Pacific Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 130. South America Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 131. South America Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 132. South America Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 133. South America Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 134. South America Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 135. South America Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 136. South America Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 137. South America Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 138. Middle East & Africa Generic Drugs Sales by Country (2016-2021e) & (K MT)
Table 139. Middle East & Africa Generic Drugs Sales by Country (2021-2026) & (K MT)
Table 140. Middle East & Africa Generic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 141. Middle East & Africa Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 142. Middle East & Africa Generic Drugs Sales by Type (2016-2021e) & (K MT)
Table 143. Middle East & Africa Generic Drugs Sales by Type (2021-2026) & (K MT)
Table 144. Middle East & Africa Generic Drugs Sales by Application (2016-2021e) & (K MT)
Table 145. Middle East & Africa Generic Drugs Sales by Application (2021-2026) & (K MT)
Table 146. Direct Channel Pros & Cons
Table 147. Indirect Channel Pros & Cons
Table 148. Generic Drugs Typical Distributors
Table 149. Generic Drugs Typical Customers
LIST OF FIGURES
Figure 1. Generic Drugs Picture
Figure 2. Global Generic Drugs Sales Market Share by Type in 2020
Figure 3. Simple Generic Drugs
Figure 4. Super Generic Drugs
Figure 5. Biosimilars
Figure 6. Global Generic Drugs Sales Market Share by Application in 2020
Figure 7. CNS
Figure 8. Cardiovascular
Figure 9. Genitourinary/Hormonal Drugs
Figure 10. Respiratory
Figure 11. Rheumatology
Figure 12. Diabetes
Figure 13. Oncology
Figure 14. Others
Figure 15. Global Generic Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 16. Global Generic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Generic Drugs Sales (2016-2026) & (K MT)
Figure 18. Global Generic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 19. Global Generic Drugs Production Capacity (2016-2026) & (K MT)
Figure 20. Global Generic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Generic Drugs Market Drivers
Figure 22. Generic Drugs Market Restraints
Figure 23. Generic Drugs Market Trends
Figure 24. Global Generic Drugs Sales Market Share by Manufacturer in 2020
Figure 25. Global Generic Drugs Revenue Market Share by Manufacturer in 2020
Figure 26. Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Generic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Generic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Generic Drugs Sales Market Share by Region (2016-2026)
Figure 30. Global Generic Drugs Revenue Market Share by Region (2016-2026)
Figure 31. North America Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Europe Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 34. South America Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 36. Global Generic Drugs Sales Market Share by Type (2016-2026)
Figure 37. Global Generic Drugs Revenue Market Share by Type (2016-2026)
Figure 38. Global Generic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 39. Global Generic Drugs Sales Market Share by Application (2016-2026)
Figure 40. Global Generic Drugs Revenue Market Share by Application (2016-2026)
Figure 41. Global Generic Drugs Price by Application (2016-2026) & (USD/MT)
Figure 42. North America Generic Drugs Sales Market Share by Type (2016-2026)
Figure 43. North America Generic Drugs Sales Market Share by Application (2016-2026)
Figure 44. North America Generic Drugs Sales Market Share by Country (2016-2026)
Figure 45. North America Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 46. United States Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Generic Drugs Sales Market Share by Type (2016-2026)
Figure 50. Europe Generic Drugs Sales Market Share by Application (2016-2026)
Figure 51. Europe Generic Drugs Sales Market Share by Country (2016-2026)
Figure 52. Europe Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Generic Drugs Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Generic Drugs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Generic Drugs Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Generic Drugs Revenue Market Share by Region (2016-2026)
Figure 62. China Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Generic Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Generic Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Generic Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Generic Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Generic Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Generic Drugs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Generic Drugs Picture
Figure 2. Global Generic Drugs Sales Market Share by Type in 2020
Figure 3. Simple Generic Drugs
Figure 4. Super Generic Drugs
Figure 5. Biosimilars
Figure 6. Global Generic Drugs Sales Market Share by Application in 2020
Figure 7. CNS
Figure 8. Cardiovascular
Figure 9. Genitourinary/Hormonal Drugs
Figure 10. Respiratory
Figure 11. Rheumatology
Figure 12. Diabetes
Figure 13. Oncology
Figure 14. Others
Figure 15. Global Generic Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 16. Global Generic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Generic Drugs Sales (2016-2026) & (K MT)
Figure 18. Global Generic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 19. Global Generic Drugs Production Capacity (2016-2026) & (K MT)
Figure 20. Global Generic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Generic Drugs Market Drivers
Figure 22. Generic Drugs Market Restraints
Figure 23. Generic Drugs Market Trends
Figure 24. Global Generic Drugs Sales Market Share by Manufacturer in 2020
Figure 25. Global Generic Drugs Revenue Market Share by Manufacturer in 2020
Figure 26. Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Generic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Generic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Generic Drugs Sales Market Share by Region (2016-2026)
Figure 30. Global Generic Drugs Revenue Market Share by Region (2016-2026)
Figure 31. North America Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Europe Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 34. South America Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Generic Drugs Revenue (2016-2026) & (USD Million)
Figure 36. Global Generic Drugs Sales Market Share by Type (2016-2026)
Figure 37. Global Generic Drugs Revenue Market Share by Type (2016-2026)
Figure 38. Global Generic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 39. Global Generic Drugs Sales Market Share by Application (2016-2026)
Figure 40. Global Generic Drugs Revenue Market Share by Application (2016-2026)
Figure 41. Global Generic Drugs Price by Application (2016-2026) & (USD/MT)
Figure 42. North America Generic Drugs Sales Market Share by Type (2016-2026)
Figure 43. North America Generic Drugs Sales Market Share by Application (2016-2026)
Figure 44. North America Generic Drugs Sales Market Share by Country (2016-2026)
Figure 45. North America Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 46. United States Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Generic Drugs Sales Market Share by Type (2016-2026)
Figure 50. Europe Generic Drugs Sales Market Share by Application (2016-2026)
Figure 51. Europe Generic Drugs Sales Market Share by Country (2016-2026)
Figure 52. Europe Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Generic Drugs Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Generic Drugs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Generic Drugs Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Generic Drugs Revenue Market Share by Region (2016-2026)
Figure 62. China Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Generic Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Generic Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Generic Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Generic Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Generic Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Generic Drugs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
